...
首页> 外文期刊>eLife journal >One reporter for in-cell activity profiling of majority of protein kinase oncogenes
【24h】

One reporter for in-cell activity profiling of majority of protein kinase oncogenes

机译:一名记者报道了大多数蛋白激酶致癌基因的细胞内活性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

In-cell profiling enables the evaluation of receptor tyrosine activity in a complex environment of regulatory networks that affect signal initiation, propagation and feedback. We used FGF-receptor signaling to identify EGR1 as a locus that strongly responds to the activation of a majority of the recognized protein kinase oncogenes, including 30 receptor tyrosine kinases and 154 of their disease-associated mutants. The EGR1 promoter was engineered to enhance trans-activation capacity and optimized for simple screening assays with luciferase or fluorescent reporters. The efficacy of the developed, fully synthetic reporters was demonstrated by the identification of novel targets for two clinically used tyrosine kinase inhibitors, nilotinib and osimertinib. A universal reporter system for in-cell protein kinase profiling will facilitate repurposing of existing anti-cancer drugs and identification of novel inhibitors in high-throughput screening studies.
机译:细胞内分析可在影响信号启动,传播和反馈的复杂调控网络环境中评估受体酪氨酸活性。我们使用FGF受体信号转导将EGR1识别为对大多数公认的蛋白激酶致癌基因(包括30种受体酪氨酸激酶及其154种与疾病相关的突变体)的激活产生强烈反应的基因座。 EGR1启动子经过工程设计以增强反式激活能力,并针对荧光素酶或荧光报告基因的简单筛选测定进行了优化。通过鉴定两种临床使用的酪氨酸激酶抑制剂尼罗替尼和奥西替尼的新靶标,证明了已开发的完全合成报告基因的功效。用于细胞内蛋白激酶分析的通用报告系统将有助于重新利用现有的抗癌药物,并在高通量筛选研究中鉴定新型抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号